Reuters logo
BRIEF-EMA recommends approval of Merck's multiple sclerosis drug
June 23, 2017 / 11:44 AM / 3 months ago

BRIEF-EMA recommends approval of Merck's multiple sclerosis drug

June 23 (Reuters) - EU Medicines Agency:

* EU Medicines Agency recommendations for June 2017

* EU Medicines Agency recommends approval of Merck KGAA multiple sclerosis drug

* EU Medicines Agency recommends approval of Abbvie Hepatitis C combination

* EU Medicines Agency recommends approval of Novartis Kisqali drug for breast cancer

* EU Medicines Agency recommends approval of Aveo drug for kidney cancer

* EU Medicines Agency recommends approval of Abbvie biosimilar drug for rheumatoid arthritis Source text for Eikon: [bit.ly/1j4Ivvu] (Bengaluru Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below